Search concepts
|
Selected Filters
|
- 1,050 - 1,100 out of 1,315 results
Search results
-
EP-CanGaroo Envelope During CIED Implant Registry Study Aziyo Biologics, Inc.
Dave, A., Mathuria, N., Schurmann, P. A. & Valderrábano, M.
10/11/21 → …
Project: Clinical Trial
-
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
10/21/21 → …
Project: Clinical Trial
-
HF-JK07 Phase 1 Study in Subjects with HFrEF Salubris Biotherapeutics, Inc.
Kassi, M., Bhimaraj, A., Guha, A., Hussain, I., Kim, J. H. & Yousefzai, R.
10/21/21 → …
Project: Clinical Trial
-
-
A Randomized Controlled Trial of cryoSPHERE (CRYOS/CRYOS-L) Ablation of Intercostal Nerves for Postoperative Pain Management in Opioid-Tolerant Patients Undergoing Robotic-Assisted Thoracoscopic Surgery
Kim, M. P., Chan, E. Y., Chihara, R., Graviss, E. A. & Moore, L. W.
11/4/21 → …
Project: Clinical Trial
-
Cardiovascular Disease Health System Registry
Nasir, K., Jones, S. L., Kash, B. A., Patel, K. V. & Vahidy, F. S.
11/16/21 → …
Project: Clinical Trial
-
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Kassi, M., Bhimaraj, A., Guha, A., Hussain, I., Kim, J. H. & Yousefzai, R.
11/16/21 → …
Project: Clinical Trial
-
-
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/23
Project: Federal Funding Agencies
-
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/23
Project: Federal Funding Agencies
-
Effects of Thyroid Hormone Metabolite Treatment for Postmenopausal Heart Repair
Filgueira, C. S., Bhimaraj, A. & Youker, K. A.
12/1/21 → 11/30/23
Project: Federal Funding Agencies
-
-
Harnessing neuroplasticity of postural sensorimotor networks using non-invasive spinal neuromodulation to maximize functional recovery after spinal cord injury
Sayenko, D., Barber, S., Horner, P. J., Kaldis, T. & Vahidy, F. S.
12/1/21 → 11/30/26
Project: Federal Funding Agencies
-
Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-Filled Breast Implants SmoothSilk in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction, and Revision Surgery
Ellsworth, IV, W. A., Gratzon, A. C. & Spiegel, A.
12/29/21 → …
Project: Clinical Trial
-
A Spectroscopic Approach to Overcome the Barriers of Early Familial Hypercholesterolemia Diagnosis
1/1/22 → 12/31/23
Project: Federal Funding Agencies
-
A structure-based machine learning framework to engineer antibody stability maturation and affinity
1/3/22 → 9/30/22
Project: Federal Funding Agencies
-
Real World Evidence (RWE) to Accelerate COVID-19 Therapeutics
1/7/22 → 5/9/22
Project: Federal Funding Agencies
-
A local immunoactive patch for the treatment of chronic wounds
1/15/22 → 6/6/22
Project: Federal Funding Agencies
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
Grow It Yourself: The Effect of Hydroponic Vegetable Gardening on Improving Quality of Life in Cancer Patients and Their Caregivers
2/1/22 → 7/31/22
Project: Federal Funding Agencies
-
The LiaFSR system and antimicrobial peptide resistance in enterococci
2/1/22 → 6/30/23
Project: Federal Funding Agencies
-
Role of YxdJK and DAK in the Enterococcal Envelope Stress Response
2/1/22 → 4/30/23
Project: Federal Funding Agencies
-
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
2/1/22 → 5/31/25
Project: Federal Funding Agencies
-
Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors
2/1/22 → 1/31/25
Project: Federal Funding Agencies
-
Bioenergetic potentiation in Alzheimer's Disease as a therapeutic strategy
2/1/22 → 1/31/25
Project: Non Profit
-
Human Astrocyte-Based Nanovesicles to Target Neuroinflammation in Alzheimer?s Disease
2/15/22 → 1/31/24
Project: Federal Funding Agencies
-
The Effect of Semaglutide in Subjects with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)
Victor, III, D. W., Kodali, S. & Shetty, A.
2/25/22 → …
Project: Clinical Trial
-
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
3/24/22 → 2/28/23
Project: Federal Funding Agencies
-
-
Capturing the genomic variation present in Cryptosporidium and cryptosporidiosis
de Paula Baptista, R.
4/1/22 → 7/31/22
Project: Federal Funding Agencies
-
-
CONNECT-AV Post-Market Surveillance of WavelinQ EndoAVF System BD Bard
4/4/22 → …
Project: Clinical Trial
-
XBP1 Inhibition and STING activation for the treatment of cancer
4/8/22 → 3/31/27
Project: Federal Funding Agencies
-
Photoacoustic Imaging to Guide Catheter Ablation of Cardiac Arrhythmias
4/18/22 → 3/31/24
Project: Federal Funding Agencies